Invite a friend to get their first reward.Claim 1000 Satoshis

I'm searching

For Hoomans

You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.

Viramune

Viramune, the brand name for nevirapine, is an antiretroviral medication used to treat HIV-1 infection. It belongs to a class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs), which work by blocking the reverse transcriptase enzyme that HIV uses to replicate. Viramune is typically prescribed in combination with other antiretroviral drugs to help manage HIV infection and reduce the amount of virus in the body, improving the function of the immune system and reducing the risk of developing complications related to HIV, such as AIDS.

Rx. Enter your prescription

How would you like to get your prescription? Select an option

Pharmacy pickup

Select from 35,000 pharmacies

Free two-day delivery

Coming soon!

Find a pharmacy near you. Enter your ZIP code

Please enter your ZIP to find pharmacies near you.

Are you a member? Sign up or log in.

Sign up for free to start earning Bitcoin rewards

Get your personal savings card. Watch your Bitcoin balance grow and get paid whenever you want.

Sign Up

Access my personal savings card

Get instant savings at my pick-up pharmacy and earn bitcoin in my NiHowdy account

Log In
backgroundbackground

Members have saved

$NaN

using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!

NaNM

worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.

How much Bitcoin can you earn with Viramune ?

The potential for Bitcoin rewards to increase and appreciate in value is a possibility to consider, which may occur over time.

See the value of your savings today

Today's Value

Bitcoin1 Bitcoin = $NaN

Bitcoin (BTC)

...

USD

$NaN

Adjust Bitcoin's potential value to see how much it could be worth

Potential Value

Bitcoin1 Bitcoin =

Bitcoin (BTC)

...

USD

$NaN

Frequently Asked Questions

How long does it take for Viramune to start working?
Open FAQClose FAQ

Viramune, when used as part of combination antiretroviral therapy, begins to reduce viral load within a few weeks of starting treatment. Full effects may take several months, depending on individual response.

Can Viramune be used alone to treat HIV?
Open FAQClose FAQ

No, Viramune is always used in combination with other antiretroviral medications to ensure the most effective suppression of the HIV virus and to prevent the development of drug resistance.

What should I do if I miss a dose of Viramune?
Open FAQClose FAQ

If you miss a dose, take it as soon as you remember. If it’s close to your next dose, skip the missed dose and take the next one as scheduled. Do not double up on doses to make up for a missed one.

Can Viramune cause liver problems?
Open FAQClose FAQ

Yes, Viramune can cause serious liver problems, particularly within the first 18 weeks of treatment. Patients should have their liver function monitored regularly, and any symptoms of liver damage should be reported immediately.

Can I drink alcohol while taking Viramune?
Open FAQClose FAQ

It is generally recommended to limit alcohol consumption while taking Viramune, as alcohol can increase the risk of liver damage, especially in combination with antiretroviral therapy.

Comprehensive Drug Guide

How Does Viramune Work?

Viramune works by inhibiting reverse transcriptase, an enzyme that HIV-1 uses to convert its RNA into DNA—a crucial step in the virus’s replication process. By blocking this enzyme, Viramune helps prevent the virus from multiplying, thereby reducing the viral load in the bloodstream. This allows the immune system to recover and function more effectively, reducing the likelihood of HIV-related illnesses.

Common Dosages

  • 200 mg tablets
  • 50 mg per 5 mL oral suspension

Typical Dosing

  • The typical starting dose is 200 mg once daily for the first 14 days (known as the lead-in period) to reduce the risk of side effects.
  • After the lead-in period, the dose is increased to 200 mg twice daily.
  • In children, dosing is based on body surface area and adjusted accordingly by the healthcare provider.

Typical Dosing

FDA Approved Indications

  • Treatment of HIV-1 infection in combination with other antiretroviral agents in both adults and children.

It is not recommended for the initial treatment of HIV due to the risk of serious side effects and is generally reserved for patients who are already stable on other antiretroviral therapy.

Who Shouldn't Take Viramune?

  • Moderate to severe liver impairment (Child-Pugh B or C)
  • Known hypersensitivity to nevirapine or any component of the formulation
  • A history of hepatotoxicity or severe skin reactions (such as Stevens-Johnson syndrome) when using nevirapine.

Advice From The Pharmacist

  • Follow the dosing schedule carefully, especially during the first 14 days (lead-in period), to reduce the risk of serious side effects like liver damage or skin reactions.
  • Viramune can be taken with or without food, but it should be taken at the same time each day to maintain consistent drug levels in the body.
  • If you experience any signs of liver damage (such as yellowing of the skin or eyes, dark urine, or severe fatigue) or a severe skin rash, stop taking the medication and contact your healthcare provider immediately.
  • Do not skip doses or stop taking Viramune without consulting your healthcare provider, as this could lead to the development of drug resistance.
  • Regular blood tests are required to monitor your liver function and ensure the medication is working effectively.

Side Effects of Viramune

Common Side Effects

  • Rash (mild to moderate)
  • Nausea
  • Fatigue
  • Headache
  • Diarrhea

Uncommon/Severe Side Effects

  • Severe liver toxicity (hepatotoxicity) or liver failure
  • Severe skin reactions (such as Stevens-Johnson syndrome or toxic epidermal necrolysis)
  • Allergic reactions (swelling of the face, lips, or throat, difficulty breathing)

Risks and Warnings of Viramune

  • Severe liver damage: Viramune can cause life-threatening hepatotoxicity, particularly in the first few weeks of treatment. Patients, especially women with higher CD4 counts, are at increased risk. Regular liver function tests are required, and the drug should be discontinued if signs of liver damage appear.
  • Severe skin reactions: Viramune can cause serious skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. The risk is higher in the first few weeks of therapy, so any new or worsening rash should be reported to a healthcare provider immediately.
  • Lead-in period: The first 14 days of treatment with a reduced dose (200 mg once daily) is essential to minimize the risk of severe side effects.

Interactions with Viramune

Common Drug Interactions

  • CYP3A4 inducers: Medications that induce the CYP3A4 enzyme, such as rifampin and St. John’s wort, can lower nevirapine levels and reduce its effectiveness.
  • Other antiretrovirals: Viramune is often used in combination with other HIV medications, but some drugs, such as protease inhibitors (like lopinavir/ritonavir), may require dose adjustments when used with nevirapine due to interactions.
  • Oral contraceptives: Nevirapine may reduce the effectiveness of hormonal birth control, so alternative contraceptive methods should be considered.

Alternatives to Viramune

  • Efavirenz (Sustiva): Another NNRTI commonly used to treat HIV-1 infection.
  • Rilpivirine (Edurant): An NNRTI used in combination with other antiretrovirals for the treatment of HIV in treatment-naive patients.
  • Doravirine (Pifeltro): Another NNRTI used in combination therapy for HIV treatment.
  • Integrase inhibitors: Such as dolutegravir (Tivicay) or bictegravir are often part of newer combination treatments for HIV.
  • Protease inhibitors: Such as atazanavir or darunavir, are also commonly used in combination with other antiretrovirals for managing HIV.